読者です 読者をやめる 読者になる 読者になる

orl.wakayama-med 2.0

和歌山県立医科大学 耳鼻咽喉科・頭頸部外科

抄読会;田村dr Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.

Current status of molecularly targeted drugs for the treatment of advanced thyroid cancer.

http://www.ncbi.nlm.nih.gov/pubmed/21383525

vandetanib
XL-184
sorafenib
motesanib
axitinib
pazopanib